Trial Profile
Multiferon treatment of non-responders to peg-IFN alfa plus ribavirin standard of care treatment - a study of the early viral kinetics during the initial 12 weeks treatment.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Aug 2011
Price :
$35
*
At a glance
- Drugs Interferon alpha (Primary) ; Peginterferon alfa; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 06 Aug 2011 New trial record